CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 88 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q4 2017. The put-call ratio across all filers is 18.43 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $0 | -100.0% | 100 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q4 2019 | $1,000 | – | 100 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 100 | -42.2% | 0.00% | – |
| Q2 2019 | $1,000 | 0.0% | 173 | +73.0% | 0.00% | – |
| Q1 2019 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q4 2018 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q3 2018 | $1,000 | -66.7% | 100 | -80.0% | 0.00% | -100.0% |
| Q2 2018 | $3,000 | -25.0% | 500 | -16.7% | 0.00% | -50.0% |
| Q1 2018 | $4,000 | 0.0% | 600 | +20.0% | 0.00% | 0.0% |
| Q4 2017 | $4,000 | 0.0% | 500 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $4,000 | 0.0% | 500 | -16.7% | 0.00% | 0.0% |
| Q2 2017 | $4,000 | – | 600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 397,168 | $43,888 | 0.01% |
| CJM Wealth Advisers, Ltd. | 30,465 | $3,366 | 0.00% |
| Tekla Capital Management LLC | 154,310 | $17,051 | 0.00% |
| McAdam, LLC | 10,006 | $6 | 0.00% |
| Aries Wealth Management | 15,400 | $1,702 | 0.00% |
| WELLS FARGO & COMPANY/MN | 342,084 | $37,800 | 0.00% |
| JPMORGAN CHASE & CO | 43,415 | $5 | 0.00% |
| NORTHERN TRUST CORP | 207,329 | $22,910 | 0.00% |
| PINNACLE ASSOCIATES LTD | 18,580 | $2,053 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |